Description

How Retatrutide WorksGLP-1 (Glucagon-like peptide-1): Slows digestion, curbs appetite, and helps you feel full.GIP (Glucose-dependent insulinotropic polypeptide): Stimulates insulin release and optimizes how the body handles fat metabolism.Glucagon (GCG): Increases calorie burning (energy expenditure) and breaks down stored fat.Clinical Effects and StatusWeight Loss: Clinical studies show patients losing an average of about 28% to 30% of their starting body weight.Additional Benefits: Studies suggest improvements in blood sugar control, reduction in fatty liver disease, and relief from knee osteoarthritis pain.Approval Status: Developed by Eli Lilly and Company, it is not yet approved by the FDA, with regulatory filings anticipated.